Neuromyelitis Optica Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neuromyelitis Optica Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuromyelitis Optica Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuromyelitis Optica Drug Overall Market Size
2.1 Global Neuromyelitis Optica Drug Market Size: 2022 VS 2029
2.2 Global Neuromyelitis Optica Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuromyelitis Optica Drug Players in Global Market
3.2 Top Global Neuromyelitis Optica Drug Companies Ranked by Revenue
3.3 Global Neuromyelitis Optica Drug Revenue by Companies
3.4 Top 3 and Top 5 Neuromyelitis Optica Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neuromyelitis Optica Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuromyelitis Optica Drug Players in Global Market
3.6.1 List of Global Tier 1 Neuromyelitis Optica Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuromyelitis Optica Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuromyelitis Optica Drug Market Size Markets, 2022 & 2029
4.1.2 Glucocorticoids
4.1.3 Immunotherapies
4.1.4 Others
4.2 By Type - Global Neuromyelitis Optica Drug Revenue & Forecasts
4.2.1 By Type - Global Neuromyelitis Optica Drug Revenue, 2018-2023
4.2.2 By Type - Global Neuromyelitis Optica Drug Revenue, 2024-2029
4.2.3 By Type - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuromyelitis Optica Drug Market Size, 2022 & 2029
5.1.2 Acute Attack
5.1.3 Remission Prophylactic Treatment
5.2 By Application - Global Neuromyelitis Optica Drug Revenue & Forecasts
5.2.1 By Application - Global Neuromyelitis Optica Drug Revenue, 2018-2023
5.2.2 By Application - Global Neuromyelitis Optica Drug Revenue, 2024-2029
5.2.3 By Application - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Neuromyelitis Optica Drug Market Size, 2022 & 2029
6.2 By Region - Global Neuromyelitis Optica Drug Revenue & Forecasts
6.2.1 By Region - Global Neuromyelitis Optica Drug Revenue, 2018-2023
6.2.2 By Region - Global Neuromyelitis Optica Drug Revenue, 2024-2029
6.2.3 By Region - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Neuromyelitis Optica Drug Revenue, 2018-2029
6.3.2 US Neuromyelitis Optica Drug Market Size, 2018-2029
6.3.3 Canada Neuromyelitis Optica Drug Market Size, 2018-2029
6.3.4 Mexico Neuromyelitis Optica Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Neuromyelitis Optica Drug Revenue, 2018-2029
6.4.2 Germany Neuromyelitis Optica Drug Market Size, 2018-2029
6.4.3 France Neuromyelitis Optica Drug Market Size, 2018-2029
6.4.4 U.K. Neuromyelitis Optica Drug Market Size, 2018-2029
6.4.5 Italy Neuromyelitis Optica Drug Market Size, 2018-2029
6.4.6 Russia Neuromyelitis Optica Drug Market Size, 2018-2029
6.4.7 Nordic Countries Neuromyelitis Optica Drug Market Size, 2018-2029
6.4.8 Benelux Neuromyelitis Optica Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Neuromyelitis Optica Drug Revenue, 2018-2029
6.5.2 China Neuromyelitis Optica Drug Market Size, 2018-2029
6.5.3 Japan Neuromyelitis Optica Drug Market Size, 2018-2029
6.5.4 South Korea Neuromyelitis Optica Drug Market Size, 2018-2029
6.5.5 Southeast Asia Neuromyelitis Optica Drug Market Size, 2018-2029
6.5.6 India Neuromyelitis Optica Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Neuromyelitis Optica Drug Revenue, 2018-2029
6.6.2 Brazil Neuromyelitis Optica Drug Market Size, 2018-2029
6.6.3 Argentina Neuromyelitis Optica Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuromyelitis Optica Drug Revenue, 2018-2029
6.7.2 Turkey Neuromyelitis Optica Drug Market Size, 2018-2029
6.7.3 Israel Neuromyelitis Optica Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Neuromyelitis Optica Drug Market Size, 2018-2029
6.7.5 UAE Neuromyelitis Optica Drug Market Size, 2018-2029
7 Neuromyelitis Optica Drug Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Neuromyelitis Optica Drug Major Product Offerings
7.1.4 Pfizer Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Fresenius
7.2.1 Fresenius Company Summary
7.2.2 Fresenius Business Overview
7.2.3 Fresenius Neuromyelitis Optica Drug Major Product Offerings
7.2.4 Fresenius Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.2.5 Fresenius Key News & Latest Developments
7.3 Teva
7.3.1 Teva Company Summary
7.3.2 Teva Business Overview
7.3.3 Teva Neuromyelitis Optica Drug Major Product Offerings
7.3.4 Teva Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.3.5 Teva Key News & Latest Developments
7.4 Sandoz
7.4.1 Sandoz Company Summary
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Neuromyelitis Optica Drug Major Product Offerings
7.4.4 Sandoz Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.4.5 Sandoz Key News & Latest Developments
7.5 Intas
7.5.1 Intas Company Summary
7.5.2 Intas Business Overview
7.5.3 Intas Neuromyelitis Optica Drug Major Product Offerings
7.5.4 Intas Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.5.5 Intas Key News & Latest Developments
7.6 Gyjtrs
7.6.1 Gyjtrs Company Summary
7.6.2 Gyjtrs Business Overview
7.6.3 Gyjtrs Neuromyelitis Optica Drug Major Product Offerings
7.6.4 Gyjtrs Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.6.5 Gyjtrs Key News & Latest Developments
7.7 NANG KUANG
7.7.1 NANG KUANG Company Summary
7.7.2 NANG KUANG Business Overview
7.7.3 NANG KUANG Neuromyelitis Optica Drug Major Product Offerings
7.7.4 NANG KUANG Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.7.5 NANG KUANG Key News & Latest Developments
7.8 Tianjin Kingyork
7.8.1 Tianjin Kingyork Company Summary
7.8.2 Tianjin Kingyork Business Overview
7.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Major Product Offerings
7.8.4 Tianjin Kingyork Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.8.5 Tianjin Kingyork Key News & Latest Developments
7.9 Baxter
7.9.1 Baxter Company Summary
7.9.2 Baxter Business Overview
7.9.3 Baxter Neuromyelitis Optica Drug Major Product Offerings
7.9.4 Baxter Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.9.5 Baxter Key News & Latest Developments
7.10 CSL
7.10.1 CSL Company Summary
7.10.2 CSL Business Overview
7.10.3 CSL Neuromyelitis Optica Drug Major Product Offerings
7.10.4 CSL Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.10.5 CSL Key News & Latest Developments
7.11 Grifols
7.11.1 Grifols Company Summary
7.11.2 Grifols Business Overview
7.11.3 Grifols Neuromyelitis Optica Drug Major Product Offerings
7.11.4 Grifols Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.11.5 Grifols Key News & Latest Developments
7.12 Octapharma
7.12.1 Octapharma Company Summary
7.12.2 Octapharma Business Overview
7.12.3 Octapharma Neuromyelitis Optica Drug Major Product Offerings
7.12.4 Octapharma Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.12.5 Octapharma Key News & Latest Developments
7.13 CBOP
7.13.1 CBOP Company Summary
7.13.2 CBOP Business Overview
7.13.3 CBOP Neuromyelitis Optica Drug Major Product Offerings
7.13.4 CBOP Neuromyelitis Optica Drug Revenue in Global Market (2018-2023)
7.13.5 CBOP Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neuromyelitis Optica Drug Market Opportunities & Trends in Global Market
Table 2. Neuromyelitis Optica Drug Market Drivers in Global Market
Table 3. Neuromyelitis Optica Drug Market Restraints in Global Market
Table 4. Key Players of Neuromyelitis Optica Drug in Global Market
Table 5. Top Neuromyelitis Optica Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Neuromyelitis Optica Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Neuromyelitis Optica Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Neuromyelitis Optica Drug Product Type
Table 9. List of Global Tier 1 Neuromyelitis Optica Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuromyelitis Optica Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Neuromyelitis Optica Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Neuromyelitis Optica Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Neuromyelitis Optica Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Neuromyelitis Optica Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Neuromyelitis Optica Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Neuromyelitis Optica Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Neuromyelitis Optica Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Neuromyelitis Optica Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Neuromyelitis Optica Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Neuromyelitis Optica Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Neuromyelitis Optica Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Neuromyelitis Optica Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Neuromyelitis Optica Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Neuromyelitis Optica Drug Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Neuromyelitis Optica Drug Product Offerings
Table 32. Pfizer Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Fresenius Company Summary
Table 35. Fresenius Neuromyelitis Optica Drug Product Offerings
Table 36. Fresenius Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Fresenius Key News & Latest Developments
Table 38. Teva Company Summary
Table 39. Teva Neuromyelitis Optica Drug Product Offerings
Table 40. Teva Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Key News & Latest Developments
Table 42. Sandoz Company Summary
Table 43. Sandoz Neuromyelitis Optica Drug Product Offerings
Table 44. Sandoz Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Sandoz Key News & Latest Developments
Table 46. Intas Company Summary
Table 47. Intas Neuromyelitis Optica Drug Product Offerings
Table 48. Intas Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Intas Key News & Latest Developments
Table 50. Gyjtrs Company Summary
Table 51. Gyjtrs Neuromyelitis Optica Drug Product Offerings
Table 52. Gyjtrs Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Gyjtrs Key News & Latest Developments
Table 54. NANG KUANG Company Summary
Table 55. NANG KUANG Neuromyelitis Optica Drug Product Offerings
Table 56. NANG KUANG Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 57. NANG KUANG Key News & Latest Developments
Table 58. Tianjin Kingyork Company Summary
Table 59. Tianjin Kingyork Neuromyelitis Optica Drug Product Offerings
Table 60. Tianjin Kingyork Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Tianjin Kingyork Key News & Latest Developments
Table 62. Baxter Company Summary
Table 63. Baxter Neuromyelitis Optica Drug Product Offerings
Table 64. Baxter Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Baxter Key News & Latest Developments
Table 66. CSL Company Summary
Table 67. CSL Neuromyelitis Optica Drug Product Offerings
Table 68. CSL Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 69. CSL Key News & Latest Developments
Table 70. Grifols Company Summary
Table 71. Grifols Neuromyelitis Optica Drug Product Offerings
Table 72. Grifols Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Grifols Key News & Latest Developments
Table 74. Octapharma Company Summary
Table 75. Octapharma Neuromyelitis Optica Drug Product Offerings
Table 76. Octapharma Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Octapharma Key News & Latest Developments
Table 78. CBOP Company Summary
Table 79. CBOP Neuromyelitis Optica Drug Product Offerings
Table 80. CBOP Neuromyelitis Optica Drug Revenue (US$, Mn) & (2018-2023)
Table 81. CBOP Key News & Latest Developments
List of Figures
Figure 1. Neuromyelitis Optica Drug Segment by Type in 2022
Figure 2. Neuromyelitis Optica Drug Segment by Application in 2022
Figure 3. Global Neuromyelitis Optica Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Neuromyelitis Optica Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Neuromyelitis Optica Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuromyelitis Optica Drug Revenue in 2022
Figure 8. By Type - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Neuromyelitis Optica Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Neuromyelitis Optica Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 16. US Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 20. Germany Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 28. China Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Neuromyelitis Optica Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Neuromyelitis Optica Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Fresenius Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sandoz Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Intas Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Gyjtrs Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NANG KUANG Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Tianjin Kingyork Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Baxter Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CSL Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Grifols Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Octapharma Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. CBOP Neuromyelitis Optica Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
